Phosphodiesterase type 5 inhibitor use does not affect heart failure hospitalizations in patients with continuous flow left ventricular.

MedStar author(s):
Citation: Unpublished 2017/10/03Form of publication: Poster PresentationYear: 2017Conference information: MedStar Heart & Vascular Institute: MedStar Health Research Symposium, North Bethesda, MD., All authors: Boyce SW, Hassanein MT, Majure DT, Mohammed SF, Sheikh FHFiscal year: FY2018Local accession number: A2017_125Date added to catalog: 2018-08-01
Holdings
Item type Current library Collection Call number Status Date due Barcode
Poster Presentation MedStar Authors Catalog Poster Available

Powered by Koha